Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UCA LOTION PRODUCT REFORMULATION

K-Number: K802650 · 1980-11-12

ApplicantVanaray Laboratories, Inc.
Decision Date1980-11-12
Product CodeGYB
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

UCA LOTION PRODUCT REFORMULATION is the device name listed in this FDA 510(k) record. The listed applicant is Vanaray Laboratories, Inc.. It received FDA 510(k) clearance on 1980-11-12 under 510(k) number K802650. The device is classified under product code GYB. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UCA LOTION PRODUCT REFORMULATION?

UCA LOTION PRODUCT REFORMULATION is a medical device that received FDA 510(k) clearance on 1980-11-12. The listed applicant is Vanaray Laboratories, Inc.. The 510(k) number is K802650.

When did UCA LOTION PRODUCT REFORMULATION receive FDA 510(k) clearance?

UCA LOTION PRODUCT REFORMULATION received FDA 510(k) clearance on 1980-11-12, under 510(k) number K802650.

Who is the listed applicant for UCA LOTION PRODUCT REFORMULATION?

The FDA 510(k) record lists Vanaray Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for UCA LOTION PRODUCT REFORMULATION?

The FDA product code for UCA LOTION PRODUCT REFORMULATION is GYB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Vanaray Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K802647ECA GEL PROUDUCT REFORMULATIONK802648UCA CREAM PRODUCT REFORMULATIONK802649UCA GEL PRODUCT REFORMAULATIONK801383ECA CREAM REFORMULATIONK792490UCA LOTIONK792489UCA CREAM

View all 10 devices →

Related Devices (Code: GYB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243749Jmoon Conductive GelShenzhen Ulike Smart Electronics Co., Ltd.K220735Avologi Gel Primer (Model: Av25)Premier North America, Inc.K222770Conductive GelTop-Rank Health Care Co., Ltd.K221724Conductive GelTone-A-Matic International, Inc.K212325EEG-acpSomnomedics GmbHK212326AC Cream - Conductive pasteSpes Medica Srl

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑